A group of rare disease charities specialising in acquired and inherited rare bone marrow failures have come together to form a collaborative alliance – Together for Heathy Marrow. The charities include Fanconi Hope, DC Action, PNH Support, DBA UK and the Aplastic Anaemia Trust. The alliance has been initiated in recognition that the operating environment
- Welcome to PNH Support!
News
14th April 2019
World’s first Soliris biosimilar launched in Russia
by Dan StantonThursday, April 11, 2019 12:04 pm Russian biopharma Generium has launched Elizaria, a biosimilar version of Alexion’s Soliris (eculizumab) developed using the SUREtechnology Platform from Selexis. Approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), Soliris (eculizumab) pulled in $3.6 billion (€3.2 billion) in global sales for Alexion Pharmaceuticals in 2018.